Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00339729
Other study ID # 999997029
Secondary ID OH97-E-N029
Status Completed
Phase N/A
First received June 19, 2006
Last updated June 30, 2017
Start date May 7, 1997
Est. completion date May 24, 2007

Study information

Verified date May 24, 2007
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We propose a population-based case-control study among 7000 elementary school children in semi-rural Johnston County, NC. Teachers will complete a screening form on each child. Controls will be randomly selected. Mothers of potential cases and controls will be interviewed by telephone about their child's symptoms of ADHD and exposure history, their family history of ADHD, and their reproductive and exposure history. Children's shed baby teeth will be analyzed for lead. Mothers will complete brief parenting scales and the Child Behavior Checklist. School records will be collected. The study goals are to identify risk factors for ADHD including preterm delivery and childhood lead exposure.


Description:

We propose a population-based case-control study among 7000 elementary school children in semi-rural Johnston County, NC. Teachers will complete a screening form on each child. Controls will be randomly selected. Mothers of potential cases and controls will be interviewed by telephone about their child's symptoms of ADHD and exposure history, their family history of ADHD, and their reproductive and exposure history. Children's shed baby teeth will be analyzed for lead. Mothers will complete brief parenting scales and the Child Behavior Checklist. School records will be collected. The study goals are to identify risk factors for ADHD including preterm delivery and childhood lead exposure.


Recruitment information / eligibility

Status Completed
Enrollment 8000
Est. completion date May 24, 2007
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years and older
Eligibility - INCLUSION CRITERIA:

During the first phase of the study, all children will be screened by the homeroom teacher, EXCEPT for those students in certain self-contained classrooms. Self-contained classrooms for students with an IQ less than 70 or autism will be omitted from the screening. In the second phase of the study, children designated as "LEP", or Low English Proficiency, will be excluded from the study.

Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention-Deficit Hyperactivity Disorder
  • Disease
  • Hyperkinesis

Locations

Country Name City State
United States NIEHS, Research Triangle Park Research Triangle Park North Carolina

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Environmental Health Sciences (NIEHS)

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT02827188 - Cognitive Restructuring in ADHD: Functional Training N/A
Recruiting NCT05374187 - Efficacy of Trigeminal Nerve Stimulation for ADHD N/A
Enrolling by invitation NCT04229251 - Online Mindfulness-Based Intervention for ADHD N/A
Completed NCT04416360 - Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak N/A
Recruiting NCT01657721 - Working Memory Training in ADHD (The Engage Study) Phase 1
Completed NCT04786730 - A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder Phase 1
Completed NCT01323192 - An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder Phase 3
Recruiting NCT05165511 - Families, Responsibility, Education, Support, and Health for Executive Function N/A
Completed NCT01886469 - A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) Phase 1/Phase 2
Completed NCT01010750 - Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) Phase 1
Recruiting NCT04729439 - Technology-Enhanced Executive Functioning Intervention for ADHD Phase 1
Completed NCT01624649 - A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors Phase 4
Completed NCT03806946 - Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
Recruiting NCT05869253 - The Efficacy of Equine Assisted Occupational Therapy, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation N/A
Completed NCT01907360 - Pharmacokinetics of HLD200 in Children and Adolescents With ADHD Phase 1/Phase 2